دورية أكاديمية

Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

التفاصيل البيبلوغرافية
العنوان: Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
المؤلفون: Noh, Sung Hoon, Park, Sook Ryun, Yang, Han-Kwang, Chung, Hyun Cheol, Chung, Ik-Joo, Kim, Sang-Woon, Kim, Hyung-Ho, Choi, Jin-Hyuk, Kim, Hoon-Kyo, Yu, Wansik, Lee, Jong Inn, Shin, Dong Bok, Ji, Jiafu, Chen, Jen-Shi, Lim, Yunni, Ha, Stella, Bang, Yung-Jue
المصدر: In The Lancet Oncology November 2014 15(12):1389-1396
قاعدة البيانات: ScienceDirect
الوصف
تدمد:14702045
DOI:10.1016/S1470-2045(14)70473-5